AnGes, Inc.
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
4563 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 茨木市彩都あさぎ七丁目７番１５号
- Website:
- https://www.anges.co.jp/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
AnGes, Inc., founded in 1999, is a biopharmaceutical company dedicated to the research and development of gene-based medicines. The company focuses on becoming a global leader in genetic pharmaceuticals by developing innovative treatments that harness the power of genes. Its core pipeline includes Hepatocyte Growth Factor (HGF) gene therapy products for blood vessel regeneration, DNA vaccines based on plasmid DNA technology, and NF-kB decoy oligonucleotides. AnGes actively engages in clinical studies and forms global alliances and manufacturing collaborations to advance its therapeutic programs and make novel treatments accessible to patients.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for AnGes, Inc. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-13 06:50 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2025-08-13 04:19 |
Interim Report
半期報告書－第27期(2025/01/01－2025/12/31)
|
Japanese | 488.0 KB | |
| 2025-03-31 04:52 |
Regulatory News Service
臨時報告書
|
Japanese | 25.5 KB | |
| 2025-03-31 03:22 |
Regulatory News Service
内部統制報告書－第26期(2024/01/01－2024/12/31)
|
Japanese | 23.7 KB | |
| 2025-03-31 03:18 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2025-03-31 03:17 |
Annual Report
有価証券報告書－第26期(2024/01/01－2024/12/31)
|
Japanese | 1.5 MB | |
| 2024-09-03 06:05 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 203.2 KB | |
| 2024-08-30 09:06 |
Prospectus
有価証券届出書（参照方式）
|
Japanese | 381.2 KB | |
| 2024-08-14 02:28 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2024-08-14 02:27 |
Interim Report
半期報告書－第26期(2024/01/01－2024/12/31)
|
Japanese | 725.7 KB | |
| 2024-05-14 02:27 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2024-05-14 02:25 |
Quarterly Report
四半期報告書－第26期第1四半期(2024/01/01－2024/03/31)
|
Japanese | 457.7 KB | |
| 2024-03-29 01:45 |
Regulatory News Service
臨時報告書
|
Japanese | 24.0 KB | |
| 2024-03-29 01:43 |
Regulatory News Service
内部統制報告書－第25期(2023/01/01－2023/12/31)
|
Japanese | 23.6 KB | |
| 2024-03-29 01:39 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB |
Automate Your Workflow. Get a real-time feed of all AnGes, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for AnGes, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
